Risdiplam 5mg tablets
NHS hospitals in England used £15,726,641 of indicative cost of Risdiplam 5mg tablets in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 0.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Risdiplam 5mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Risdiplam 5mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University College London Foundation Tr | £4,147,425 |
| Salford Royal Nhs Foundation Trust | £2,101,362 |
| St George's Univ Hosps Foundation Nhst | £1,972,331 |
| Cambridge Univ Hosp Nhs Foundation Trust | £995,382 |
| Sheffield Children's Nhs Ft | £719,545 |
| Univ Hpls Bristol Nhs Foundation Trust | £629,355 |
| King's College Hpl Nhs Foundation Trust | £626,722 |
| Oxford University Hospitals Nhs Ft | £589,856 |
| University Hospital Southampton Nhs Ft | £516,124 |
| Sheffield Teaching Hospitals Nhs Trust | £405,526 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.